UY39368A - Composiciones para modular el empalme - Google Patents

Composiciones para modular el empalme

Info

Publication number
UY39368A
UY39368A UY0001039368A UY39368A UY39368A UY 39368 A UY39368 A UY 39368A UY 0001039368 A UY0001039368 A UY 0001039368A UY 39368 A UY39368 A UY 39368A UY 39368 A UY39368 A UY 39368A
Authority
UY
Uruguay
Prior art keywords
splicing
modular
compositions
small
modulate
Prior art date
Application number
UY0001039368A
Other languages
English (en)
Inventor
Michael LUZZIO
Tiansheng Wang
Brian Lucas
Original Assignee
Skyhawk Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Skyhawk Therapeutics Inc filed Critical Skyhawk Therapeutics Inc
Publication of UY39368A publication Critical patent/UY39368A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En la presente descripción se describen compuestos moduladores de empalme de molécula pequeña que modulan el empalme del ARNm, tal como el pre-ARNm, codificado por genes, y métodos de uso de los compuestos moduladores de empalme de molécula pequeña para modular el empalme y tratar enfermedades y afecciones.
UY0001039368A 2020-08-05 2021-08-04 Composiciones para modular el empalme UY39368A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063061742P 2020-08-05 2020-08-05

Publications (1)

Publication Number Publication Date
UY39368A true UY39368A (es) 2022-01-31

Family

ID=80117649

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039368A UY39368A (es) 2020-08-05 2021-08-04 Composiciones para modular el empalme

Country Status (13)

Country Link
US (1) US20230331718A1 (es)
EP (1) EP4192454A1 (es)
JP (1) JP2023538524A (es)
KR (1) KR20230048106A (es)
CN (1) CN116171153A (es)
AR (1) AR123150A1 (es)
AU (1) AU2021320763A1 (es)
CA (1) CA3188104A1 (es)
IL (1) IL300352A (es)
MX (1) MX2023001558A (es)
TW (1) TW202216697A (es)
UY (1) UY39368A (es)
WO (1) WO2022031838A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114007613A (zh) * 2019-02-05 2022-02-01 斯基霍克疗法公司 用于调节剪接的方法和组合物
EP3920928A4 (en) 2019-02-06 2022-09-28 Skyhawk Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MODULATION OF SPLICING

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2579949T3 (es) * 2010-02-05 2016-08-17 Heptares Therapeutics Limited Derivados de 1,2,4-triazin-4-amina
CN112135815A (zh) * 2018-03-27 2020-12-25 Ptc医疗公司 用于治疗亨廷顿氏病的化合物
US11530207B2 (en) * 2018-04-10 2022-12-20 Skyhawk Therapeutics, Inc. Compounds for the treatment of cancer
CN114007612A (zh) * 2019-02-05 2022-02-01 斯基霍克疗法公司 用于调节剪接的方法和组合物
CN114007613A (zh) * 2019-02-05 2022-02-01 斯基霍克疗法公司 用于调节剪接的方法和组合物

Also Published As

Publication number Publication date
IL300352A (en) 2023-04-01
KR20230048106A (ko) 2023-04-10
MX2023001558A (es) 2023-04-26
JP2023538524A (ja) 2023-09-08
AR123150A1 (es) 2022-11-02
WO2022031838A1 (en) 2022-02-10
AU2021320763A1 (en) 2023-03-30
CA3188104A1 (en) 2022-02-10
EP4192454A1 (en) 2023-06-14
CN116171153A (zh) 2023-05-26
US20230331718A1 (en) 2023-10-19
TW202216697A (zh) 2022-05-01

Similar Documents

Publication Publication Date Title
CO2019011543A2 (es) Inhibidores de pd-1/pd-l1
CO2020009861A2 (es) Inhibidores pd-1/pd-l1
CO2022010241A2 (es) Inhibidores de sos1
CL2018001685A1 (es) Compuestos heterociclicos como inmuno moduladores.
CL2021000084A1 (es) Inhibidores de pd-1/pd-l1
CL2020000075A1 (es) Carboxamidas como moduladores de los canales de sodio.
CL2023002090A1 (es) Inhibidores de kras tricíclicos fusionados
CO2017011183A2 (es) Inhibidores de indolamina-2,3-dioxigenasa composiciones que los contienen y métodos de preparación
CL2020002146A1 (es) Derivados de n-(fenil)-2-(fenil)pirimidina-4-carboxamida y compuestos relacionados como inhibidores hpki para tratar el cáncer.
CL2022002341A1 (es) Compuestos y métodos para modular el empalme
UY39368A (es) Composiciones para modular el empalme
CO2019005059A2 (es) Inhibidores de magl
CO2017003838A2 (es) Compuestos de aminopurina sustituida, composiciones del mismo, y métodos de tratamiento con los mismos
CO2019005038A2 (es) Inhibidores de magl
ECSP19083923A (es) Inhibidores pirazólicos de magl
ECSP19084085A (es) Inhibidores pirazólicos de magl
CO2017011017A2 (es) Azabenzimidazoles y su uso como moduladores del receptor ampa
CL2021001461A1 (es) Moduladores de trex1
CL2022002779A1 (es) Compuestos y métodos para modular el proceso de corte y empalme
CO2021001172A2 (es) Composiciones y métodos para el tratamiento de enfermedades o condiciones relacionadas con inflamasomas
ECSP22043592A (es) Inhibidores de egfr alost?ricos y m?todos de uso de los mismos
CO2024001285A2 (es) Compuestos tricíclicos como inhibidores de kras
MX2020004678A (es) Uso de profarmacos de riluzol para tratar ataxias.
CL2021001656A1 (es) Compuestos de imidazopiridina e imidazopiridina y sus usos.
UY37800A (es) AGENTES DE iARN PARA LA INHIBICIÓN DE LA EXPRESIÓN DE ALFA-ENaC Y MÉTODOS DE USO